FDA
-
-
-
-
-
-
-
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
-
-
-
-
-
-
-
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
-
-
-
-
-
-
-
Quanterix (QTRX) Announces FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
-
-
-
-
-
-
-
Quanterix (QTRX) Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis
-
-
-
-
-
-
-
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
-
-
-
-
-
-
-
Quanterix (QTRX) Granted FDA Breakthrough Device Designation for Blood-Based pTau-181 Assay for Alzheimer’s Disea
-
-
-
-
-
-
-
Quanterix's (QTRX) Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples
-
323,613 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

